STOCK TITAN

Champions Oncology, Inc. (CSBR) Net Income by Year

CSBR

Champions Oncology, Inc. reported a net loss of $1K in fiscal year 2026. This represents a decrease of 125.0% from the prior fiscal year. Over the trailing 12 months, Q2 FY2026 through Q1 FY2027, the same line adds up to $39K in net income. The table below carries 15 fiscal years, from 2012 to 2026, and the quarters Champions Oncology, Inc. has filed alongside them.

FY2026 annual
Net Income -$1K
YoY -125.0%
Source SEC Filings (10-K/10-Q) Latest period Q1 FY2027, ended Jul 31, 2026 Reported Currency USD

Annual figures, oldest first. Point at a bar to read its period.

CSBR Net Income by Fiscal Year

Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.

MetricTTMFY2610-KFY2510-KFY2410-KFY2310-KFY2210-KFY2110-KFY2010-KFY1910-KFY1810-KFY1710-KFY1610-KFY1510-KFY1410-KFY1310-KFY1210-K
Net Income$39K-$1K-125.0%$5K+164.6%-$7K+99.9%-$5.3M-1073.5%$548K+51.4%$362K+117.3%-$2.1M-1735.2%$128K+108.7%-$1.5M+78.6%-$6.9M+34.1%-$10.4M+20.5%-$13.1M-77.4%-$7.4M-17.0%-$6.3M+26.9%-$8.7M

TTM is the trailing twelve months, Q2 FY2026 through Q1 FY2027, summed from the four most recent quarterly filings.

CSBR Net Income by Quarter

Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.

MetricQ1'2710-QQ4'2610-QQ3'2610-QQ2'2610-QQ1'2610-QQ4'2510-KQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-KQ3'2410-QQ2'2410-Q
Net Income-$426K+8.6%$476K+107.3%-$279K-106.2%$268K-63.2%-$466K-135.5%-$6.5M-191.2%$4.5M+277.7%$728K+135.2%$1.3M+151.2%$7.2M+379.6%-$2.5M-3.7%-$2.1M-12843.8%

What net income means

Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line.

More Champions Oncology, Inc. financials

Frequently Asked Questions

What was Champions Oncology, Inc.'s net income in fiscal year 2026?

Champions Oncology, Inc. reported a net loss of $1K in fiscal year 2026.

How fast is Champions Oncology, Inc.'s net income growing?

Champions Oncology, Inc. (CSBR) net income fell by 125.0% year over year, from $5K to -$1K in fiscal year 2026.

What is Champions Oncology, Inc.'s net income over the last twelve months?

Champions Oncology, Inc. (CSBR) reported $39K in net income over the trailing 12 months, Q2 FY2026 through Q1 FY2027, summed from the four most recent quarterly filings.

Across the 15 fiscal years this page covers, Champions Oncology, Inc. (CSBR) net income went from -$8.7M in fiscal year 2012 to -$1K in fiscal year 2026.

Champions Oncology, Inc. (CSBR) reported -$426K in net income in Q1 2027. This represents an increase of 8.6% from the same quarter a year earlier.

Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line. This page lists what Champions Oncology, Inc. (CSBR) reported on that line in every period on record.